d'Arminio Monforte A - Search Results

1

Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study).

Bai F, Aldieri C, Cattelan A, Raumer F, Di Meco E, Moioli MC, Tordato F, Morelli P, Borghi F, Rizzi M, Van Hauwermeiren E, Castelli F, Migliorino G, Menzaghi B, Rizzardini G, Saracino A, Cascio A, Puoti M, d'Arminio Monforte A, Marchetti G. Bai F, et al. Expert Rev Anti Infect Ther. 2020 Dec;18(12):1271-1279. doi: 10.1080/14787210.2020.1798227. Epub 2020 Aug 14. Expert Rev Anti Infect Ther. 2020. PMID: 32797758 Free article.

2

Immunovirological outcomes in 70 HIV-1-infected patients who switched to lopinavir/ritonavir after failing at least one protease inhibitor-containing regimen: a retrospective cohort study.

Bongiovanni M, Bini T, Tordato F, Cicconi P, Melzi S, Repetto D, Sollima S, Rusconi S, d'Arminio Monforte A. Bongiovanni M, et al. J Antimicrob Chemother. 2003 Jan;51(1):171-4. doi: 10.1093/jac/dkg045. J Antimicrob Chemother. 2003. PMID: 12493805 Free article.

3

Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir: safety and efficacy outcomes.

Chiesa E, Bini T, Adorni F, Capetti A, Rizzardini G, Faggion I, Mussini C, Sollima S, Melzi S, Bongiovanni M, Tordato F, Cicconi P, Castelnuovo B, Rusconi S, d'Arminio Monforte A. Chiesa E, et al. Antivir Ther. 2003 Feb;8(1):27-35. Antivir Ther. 2003. PMID: 12713061

4

Virological success of lopinavir/ritonavir salvage regimen is affected by an increasing number of lopinavir/ritonavir-related mutations.

Bongiovanni M, Bini T, Adorni F, Meraviglia P, Capetti A, Tordato F, Cicconi P, Chiesa E, Cordier L, Cargnel A, Landonio S, Rusconi S, d'Arminio Monforte A. Bongiovanni M, et al. Antivir Ther. 2003 Jun;8(3):209-14. Antivir Ther. 2003. PMID: 12924537 Clinical Trial.

5

Declining incidence of AIDS and increasing prevalence of AIDS presenters among AIDS patients in Italy.

Castelnuovo B, Chiesa E, Rusconi S, Adorni F, Bongiovanni M, Melzi S, Cicconi P, Tordato F, Meroni L, Bini T, d'Arminio Monforte A. Castelnuovo B, et al. Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):663-9. doi: 10.1007/s10096-003-1038-8. Epub 2003 Oct 21. Eur J Clin Microbiol Infect Dis. 2003. PMID: 14569430

6

Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir.

Cicconi P, Bongiovanni M, Melzi S, Tordato F, d'Arminio Monforte A, Bini T. Cicconi P, et al. Int J Antimicrob Agents. 2004 Sep;24(3):284-5. doi: 10.1016/j.ijantimicag.2004.04.005. Int J Antimicrob Agents. 2004. PMID: 15325433

7

The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug?

Puoti M, Cozzi-Lepri A, Ancarani F, Bruno R, Ambu S, Ferraro T, Tundo P, Santantonio T, Toti M, Bonasso M, d'Arminio Monforte A; HepaI.CoNA Study Group; ICoNA Study Group. Puoti M, et al. Antivir Ther. 2004 Oct;9(5):811-7. Antivir Ther. 2004. PMID: 15535419 Clinical Trial.

8

Use of lopinavir/ritonavir in HIV-infected patients failing a first-line protease-inhibitor-containing HAART.

Bongiovanni M, Chiesa E, Di Biagio A, Meraviglia P, Capetti A, Tordato F, Cicconi P, Biasi P, Bini T, d'Arminio Monforte A. Bongiovanni M, et al. J Antimicrob Chemother. 2005 Jun;55(6):1003-7. doi: 10.1093/jac/dki113. Epub 2005 Apr 11. J Antimicrob Chemother. 2005. PMID: 15824089

9

Subclinical hypothyroidism in HIV-infected subjects.

Bongiovanni M, Adorni F, Casana M, Tordato F, Tincati C, Cicconi P, Bini T, d'Arminio Monforte A. Bongiovanni M, et al. J Antimicrob Chemother. 2006 Nov;58(5):1086-9. doi: 10.1093/jac/dkl360. Epub 2006 Sep 1. J Antimicrob Chemother. 2006. PMID: 16950823

10

Significant link between sCD30 changes and HIV viremia in patients treated with HAART.

Biswas P, Cozzi-Lepri A, Delfanti F, Galli A, Colangeli V, Moioli MC, Scarchilli A, Abrescia N, Vigevani G, D'Arminio-Monforte A, Novati R, Lazzarin A. Biswas P, et al. J Med Virol. 2006 Dec;78(12):1513-9. doi: 10.1002/jmv.20733. J Med Virol. 2006. PMID: 17063513 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

590 results

Search Page